A new genetic tool to improve immune-compromised mouse models: Derivation and CRISPR/Cas9-mediated targeting of NRG embryonic stem cell lines

Genesis : the Journal of Genetics and Development
Javier Martin GonzalezJörg Cammenga

Abstract

Development of human hematopoietic stem cells and differentiation of embryonic stem (ES) cells/induced pluripotent stem (iPS) cells to hematopoietic stem cells are poorly understood. NOD (Non-obese diabetic)-derived mouse strains, such as NSG (NOD-Scid-il2Rg) or NRG (NOD-Rag1-il2Rg), are the best available models for studying the function of fetal and adult human hematopoietic cells as well as ES/iPS cell-derived hematopoietic stem cells. Unfortunately, engraftment of human hematopoietic stem cells is very variable in these models. Introduction of additional permissive mutations into these complex genetic backgrounds of the NRG/NSG mice by natural breeding is a very demanding task in terms of time and resources. Specifically, since the genetic elements defining the NSG/NRG phenotypes have not yet been fully characterized, intense backcrossing is required to ensure transmission of the full phenotype. Here we describe the derivation of embryonic stem cell (ESC) lines from NRG pre-implantation embryos generated by in vitro fertilization followed by the CRISPR/CAS9 targeting of the Gata-2 locus. After injection into morula stage embryos, cells from three tested lines gave rise to chimeric adult mice showing high contribution of the...Continue Reading

References

Feb 6, 2008·The Journal of Immunology : Official Journal of the American Association of Immunologists·Lina A ThorénSten-Eirik W Jacobsen
Jun 6, 2009·Nature Medicine·Jennifer NicholsAnne Cooke
Dec 24, 2011·The International Journal of Biochemistry & Cell Biology·Neil P RodriguesTariq Enver
Sep 22, 2012·The Journal of Clinical Investigation·Kim-Chew LimJames Douglas Engel
Oct 26, 2013·Nature Protocols·F Ann RanFeng Zhang
Nov 15, 2013·Blood·Michael A SpinnerSteven M Holland
Dec 19, 2013·Blood·Rachel E DickinsonMatthew Collin
Jul 16, 2014·Cell Stem Cell·Kadriye Nehir CosgunClaudia Waskow
Jul 25, 2014·Nature Protocols·Hui YangRudolf Jaenisch
Sep 26, 2015·Protein & Cell·Kang LiuHongkui Deng

❮ Previous
Next ❯

Citations

Jan 13, 2022·Neural Regeneration Research·Taiwei DongJian Wang

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR Ribonucleases Deactivation

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on mechanisms that underlie deactivation of CRISPR ribonucleases. Here is the latest research.

CRISPR (general)

Clustered regularly interspaced short palindromic repeats (CRISPR) are DNA sequences in the genome that are recognized and cleaved by CRISPR-associated proteins (Cas). CRISPR-Cas system enables the editing of genes to create or correct mutations. Discover the latest research on CRISPR here.

CRISPR for Genome Editing

Genome editing technologies enable the editing of genes to create or correct mutations. Clustered regularly interspaced short palindromic repeats (CRISPR) are DNA sequences in the genome that are recognized and cleaved by CRISPR-associated proteins (Cas). Here is the latest research on the use of CRISPR-Cas system in gene editing.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.